The Group's principal activities are discovering and developing drugs for the treatment of serious unmet medical needs. The Group is engaged in the development of proprietary small molecule drugs for the treatment of human immunodeficiency virus (HIV), diabetes, oncology and inflammation. The Group operates in the United States, Canada, Germany, Sweden, and the United Kingdom.
Alacra Alerts:
Receive alerts on the latest reports on Incyte Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
